New Zealand Gazette – 1998 – No. 48

Page 1102

✨ Medicine Approvals



NEW ZEALAND GAZETTE

No. 48

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Hydrofluoric acid 0.722% w/v (of a 48% solution) sodium fluoride 2% w/v equivalent to 1.23% w/v fluoride in 250 mL Solution, oral, topical Pharmacare Manufacturing Pty Limited, Laverton North, Victoria, Australia Colgate Fluorocare Acidulated Phosphate Fluoride, Professional Fluoride Solution
Sodium fluoride 2.72% w/v equivalent to 1.23% w/v fluoride in 30 mL, 250 mL Gel, oral, topical Pharmacare Manufacturing Pty Limited, Laverton North, Victoria, Australia Colgate Neutrafluor Neutral Sodium Fluoride, Fluoride Topical Gel
Chlorhexidine gluconate 0.2% w/v in 30 mL, 250 mL Gel, oral, topical Pharmacare Manufacturing Pty Limited, Laverton North, Victoria, Australia Colgate Periogard Chlorhexidine Antiseptic Mouth Gel
Chlorhexidine gluconate 2% w/v in 30 mL Gel, oral, topical Pharmacare Manufacturing Pty Limited, Laverton North, Victoria, Australia Colgate Periogard Chlorhehex Forte Antiseptic Mouth Gel
Valsartan 80 mg, 160 mg Capsules Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Diovan
Erythromycin 2% w/w, 4% w/w in 30 g Gel, topical Laboratoires Galderma, Alby Sur Cheran, France Eryacne
Alanine 16.0 g/L, arginine 11.3 g/L, aspartic acid 3.4 g/L, glutamic acid 5.6 g/L, glycyl-glutamine 5.6 g/L, histidine 6.8 g/L, isoleucine 5.6 g/L, leucine 7.9 g/L, lysine-acetate 12.7 g/L, methionine 5.6 g/L, phenylalanine 5.85 g/L, proline 6.8 g/L, serine 4.5 g/L, threonine 5.6 g/L, tryptophan 1.9 g/L, valine 7.3 g/L in 250 mL, 500 mL, 1 L Solution, infusion Pharmacia GmbH., Platting, Germany Glamin
Paracetamol 500 mg Tablet Herron Pharmaceuticals Pty Limited, Tennyson, Queensland, Australia Herron Paracetamol
Cadexomer iodine 60% w/w in 5 g, 10 g, 17 g Dressing, medicated Perstorp Pharma, Ideon, Sweden HydroHeal Medicated
Cadexomer iodine 50% w/w in 10 g, 20 g, 40 g Ointment, skin Perstorp Pharma, Ideon, Sweden HydroHeal Medicated
Dextromethorphan hydrobromide 1 mg/mL in 100 mL, 200 mL Solution, oral PSM Holdings Limited, Wiri, Auckland Medico Tickly Cough Mixture
Levonorgestrel 52 mg equivalent to 20 µg/24 hours Intrauterine contraceptive device Leiras Oy, Turku, Finland Mirena
Mometasone furoate monohydrate 50 µg/dose Spray, nasal, metered dose Schering-Plough Laboratories NV., Heist-op-den-Berg, Belgium and Schering-Plough Products Inc., Manati, Puerto Rico Nasonex
Orphenadrine citrate 35 mg, paracetamol 450 mg Tablet 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Norgesic
Codeine phosphate 8 mg, doxylamine succinate 5 mg, paracetamol 500 mg Capsule SmithKline Beecham Pharmaceuticals, Dandenong, Victoria, Australia and SmithKline Beecham (Australia) Pty Limited, Ermington, New South Wales, Australia Panadeine Plus
Potassium chloride 2 mmol/mL in 25 mL Solution, oral McGaw Biomed Limited, Point Chevalier, Auckland Potassium Chloride
Ropinirole hydrochloride 0.285 mg, 0.57 mg, 1.14 mg, 2.28 mg, 5.7 mg equivalent to 0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg ropinirole Tablets, film coated SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England Requip


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1998, No 48


NZLII — PDF NZ Gazette 1998, No 48




✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
24 March 1998
Medicines Act 1981, New Medicines, Hydrofluoric acid, Sodium fluoride, Chlorhexidine gluconate, Valsartan, Erythromycin, Alanine, Paracetamol, Cadexomer iodine, Dextromethorphan hydrobromide, Levonorgestrel, Mometasone furoate monohydrate, Orphenadrine citrate, Codeine phosphate, Potassium chloride, Ropinirole hydrochloride